PropertyValue
?:abstract
  • Corona Virus Disease 2019 (COVID-9) is an acute respiratory infection caused by extreme acute coronavirus-2 (SARS-CoV-2) respiratory syndrome WHO has designated COVID-19 as a pandemic with a very high mortality rate and increasing very rapidly, in only 3 months COVID- 19 has infected 1 133046 people and in many cases only 14 days COVID-19 has caused death? With very high mortality and mordibility rates, no effective and safe of antivirus treatment has yet been found to cure COVID-19, so research is needed to find the most effective and safe of antivirus drugs to cure COVID-19 To know the best and safe of antivirus medication to cure COVID-19 This research uses a structured analysis focused on preferred reporting items for systematic reviews and meta-analyzes (PRISMA) in order to classify all existing literature with appropriate keywords The database using PRISMA (Preferred Reporting Items for Systematic Reviews & Meta Analyses) for instruments and used flowcharts based on the 2009 PRISMA checklist and based on inclusion and exclusion criteria, we found 6 anti-virus drugs used to treat SARS-CoV-1 or MERS-CoV and very potential to treat COVID-19, that is Favipiravir (Avigan, Favilavir), Lopinavir and Ritonavir (LPV / RTV;Kaletra), Neuraminidase inhibitors (eg, oseltamivir), Umifenovir (Arbidol) Remdesivir, and Baloxavir The most efficacy and safe of anti-virus is Favipiravir because this drug can improve significantly time-to-relief for fever and cough and is associated with manageable adverse effects © 2020 EManuscript Technologies All rights reserved
is ?:annotates of
?:creator
?:journal
  • Systematic_Reviews_in_Pharmacy
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • The efficacy and safety of antivirus drugs for COVID-19: A systematic review
?:type
?:who_covidence_id
  • #829037
?:year
  • 2020

Metadata

Anon_0  
expand all